In Vitro Susceptibility of Campylobacter jejuni to Rokitamycin
AUTOR(ES)
Miyake, Yoichiro
RESUMO
The susceptibilities of 100 clinical isolates of Campylobacter jejuni to rokitamycin, a new macrolide, and eight other oral antibiotics were tested by using a broth microdilution method. Rokitamycin demonstrated antibacterial activity that was higher than those of fosfomycin and the tetracyclines and comparable to those of erythromycin and clindamycin, whereas it was slightly less active than the quinolones.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=175996Documentos Relacionados
- In vitro antimicrobial susceptibility, plasmid analysis, and serotyping of epidemic-associated Campylobacter jejuni.
- Susceptibility of Campylobacter jejuni and Campylobacter coli to macrolides and related compounds.
- In vitro susceptibilities of Campylobacter jejuni and Campylobacter coli to azithromycin and erythromycin.
- In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents.
- In Vitro Susceptibility of Campylobacter fetus subsp. jejuni to N-Formimidoyl Thienamycin, Rosaramicin, Cefoperazone, and Other Antimicrobial Agents
